Drug information for CLARITIN REDITABS
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, ORALLY DISINTEGRATING; ORAL
10MG
Over The Counter
(Reference Drug)
LORATADINE
Loratadine
SCHERING PLOUGH
20704
2009-02-03 Letter
2008-10-23 Letter
2007-03-02 Review
2007-03-02 Review
2006-01-30 Letter
2004-12-07 Review
2003-11-25 Letter
2002-11-27 Letter
TABLET, ORALLY DISINTEGRATING; ORAL
5MG
Over The Counter
(Reference Drug)
LORATADINE
Loratadine
SCHERING PLOUGH
21993
2008-10-23 Letter
2008-10-03 Review
2006-12-14 Label
2006-12-14 Letter
Drug Adverse Effects information for CLARITIN REDITABS
Role code
Indications
Reaction
# Reports
C
COLORECTAL CANCER
CHOLANGITIS
1
C
COLORECTAL CANCER
DERMATITIS ACNEIFORM
1
C
COLORECTAL CANCER
DRY SKIN
1
C
COLORECTAL CANCER
HYPOCALCAEMIA
1
C
COLORECTAL CANCER
HYPOKALAEMIA
1
C
COLORECTAL CANCER
HYPOMAGNESAEMIA
1
C
COUGH
DROWNING
1
C
COUGH
DRUG ERUPTION
1
C
DIABETES MELLITUS
BLADDER CANCER
1
C
EMPHYSEMA
BRONCHITIS
6
C
EMPHYSEMA
PNEUMONIA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
DROWNING
7
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG ERUPTION
7
C
PROPHYLAXIS
BRONCHITIS
5
C
PROPHYLAXIS
PNEUMONIA
5
Ads by Google